← Leaderboards
A. Clementina Mesaros
University Of Pennsylvania
$2,395,433
Attributed
$3,689,302
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,689,302 · 5
By mechanism
U01$1,940,804 · 1
S10$737,125 · 1
P30$525,748 · 2
R21$485,625 · 1
Top collaborators
- Joseph A. Baur2 shared
- Ravinder Reddy2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert B Wilson$8,097,885
- Joseph A. Baur$17,043,751
- Ian Alexander Blair$30,276,296
- Andrew B. Dancis$9,246,751
- Trevor M. Penning$29,812,455
Others in their field
Other Emerging Leaders on “Metabolomics”
- Kathleen Maletic Neuzil · Emory University$27,446,978
- Michael W Rabin · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
Research focus
MetabolomicsMass Spectrum AnalysisSamplingMethodologyInterestBiological MarkersResolutionLiquid ChromatographyProteomicsAnimal ModelCalibrationCellsMetabolismResearch PersonnelLaboratoriesIsotopesInstrumentationBiomarker DiscoveryCohortComputer SoftwareLiquid Chromatography Mass SpectrometryIn VivoMethod DevelopmentSignal Transduction
Grant awards (6)
Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization$939,100
U01 · FY2025 · AG
Biomolecular Mass Spectrometry Core$272,429
P30 · FY2025 · ES · contact PI
Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization$1,001,704
U01 · FY2024 · AG
Thermo IQ-X high-resolution mass spectrometer$737,125
S10 · FY2024 · OD · contact PI
Translational Biomarker Facility Core$253,319
P30 · FY2022 · ES · contact PI
Lipid metabolism disruption as a consequence of mitochondrial dysfunction in Friedreich's ataxia$485,625
R21 · FY2020 · NS · contact PI